Results of CD30 CAR-T Cell Therapy Trial Shows Promise for Hodgkin Lymphoma Patients
Clinical-stage cell therapy company, Tessa Therapeutics announced the results of two independent Phase 1/2 trials of autologous CD30 CAR-T cell therapy in patients with relapsed or refractory Hodgkin...